- Home
- CRNX vs LIN Comparison
CRNX vs LIN Comparison
Compare CRNX & LIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- LIN
- Stock Information
- Founded
- CRNX 2008
- LIN 1879
- Country
- CRNX United States
- LIN United Kingdom
- Employees
- CRNX N/A
- LIN N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- LIN Major Chemicals
- Sector
- CRNX Health Care
- LIN Industrials
- Exchange
- CRNX Nasdaq
- LIN Nasdaq
- Market Cap
- CRNX 2.8B
- LIN N/A
- IPO Year
- CRNX 2018
- LIN N/A
- Fundamental
- Price
- CRNX $30.51
- LIN $467.58
- Analyst Decision
- CRNX Strong Buy
- LIN Buy
- Analyst Count
- CRNX 10
- LIN 12
- Target Price
- CRNX $75.00
- LIN $502.10
- AVG Volume (30 Days)
- CRNX 942.0K
- LIN 1.9M
- Earning Date
- CRNX 05-08-2025
- LIN 05-01-2025
- Dividend Yield
- CRNX N/A
- LIN 1.28%
- EPS Growth
- CRNX N/A
- LIN 6.99
- EPS
- CRNX N/A
- LIN 13.78
- Revenue
- CRNX $760,000.00
- LIN $33,017,000,000.00
- Revenue This Year
- CRNX $343.70
- LIN $2.62
- Revenue Next Year
- CRNX $733.93
- LIN $5.76
- P/E Ratio
- CRNX N/A
- LIN $33.93
- Revenue Growth
- CRNX N/A
- LIN 0.78
- 52 Week Low
- CRNX $24.10
- LIN $408.65
- 52 Week High
- CRNX $62.53
- LIN $487.49
- Technical
- Relative Strength Index (RSI)
- CRNX 46.97
- LIN 60.13
- Support Level
- CRNX $29.05
- LIN $453.57
- Resistance Level
- CRNX $30.99
- LIN $468.13
- Average True Range (ATR)
- CRNX 1.43
- LIN 6.20
- MACD
- CRNX -0.09
- LIN 1.25
- Stochastic Oscillator
- CRNX 32.27
- LIN 94.85
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.